More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
American Veterinarian, Authority Times, and the Oracle Dispatch Provide Coverage of Medical Marijuana, Inc. Achievements This Week

American Veterinarian, Authority Times, and the Oracle Dispatch Provide Coverage of Medical Marijuana, Inc. Achievements This Week

by adminAdrianRamirez | Jun 15, 2018 | HempMeds, Kannaway, Media Coverage

Further expansion into Latin America, new CBD-infused pet treats, and best gifts for dads and grads top Medical Marijuana, Inc.’s headlines this week. Once again, Medical Marijuana, Inc. and our family of companies were featured by national media outlets as we worked...
Medical Marijuana, Inc. Applauds DEA’s Recent Clarification on CBD; Company’s Products Federally Legal

Medical Marijuana, Inc. Applauds DEA’s Recent Clarification on CBD; Company’s Products Federally Legal

by adminAdrianRamirez | Jun 14, 2018 | Press Releases

SAN DIEGO, June 14, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that the company applauds the Drug Enforcement Administration (DEA) for its recent statement on the legality of...
Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever CBD Product in Argentina

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever CBD Product in Argentina

by adminAdrianRamirez | Jun 13, 2018 | HempMeds, HempMeds Mexico, Press Releases

SAN DIEGO, June 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® today announced the historic authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) cannabidiol (CBD) hemp...
New York’s PIX 11, CBS Sports, Business Insider, and VICE Reveal Medical Marijuana, Inc.’s Role in the Cannabis Industry

New York’s PIX 11, CBS Sports, Business Insider, and VICE Reveal Medical Marijuana, Inc.’s Role in the Cannabis Industry

by adminAdrianRamirez | Jun 8, 2018 | Media Coverage

CBD in the NFL, New York’s largest cannabis industry event, CBD pet products, and more made headlines this week in Medical Marijuana, Inc.’s top news stories. Medical Marijuana, Inc. and our subsidiary companies were once again in the news this week as major national...
Benzinga, Bustle, CNN, and MSN Feature the Medical Marijuana, Inc. Portfolio of Companies This Week

Benzinga, Bustle, CNN, and MSN Feature the Medical Marijuana, Inc. Portfolio of Companies This Week

by adminAdrianRamirez | Jun 1, 2018 | Kannalife Sciences, Media Coverage

Medical Marijuana, Inc. companies Kannalife™ Sciences, Kannaway, and HempMeds® were included in media coverage of the cannabis industry this week. Medical Marijuana, Inc. achievements like our three months of record growth to begin the year, the creation of a CBD-like...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.